Aseptic technique for people who were never taught it
A needle blunts on first use. Reuse is uncomfortable, and it is a documented contributor to lipohypertrophy.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Technique
A pharmacist catches most of these in licensed practice. In this market there is no pharmacist, so the checks have to be structural.
What licensed practice has and this market does not is a second reader. A pharmacist checks the arithmetic, a label states the concentration, and a dispensing system flags an implausible quantity. Somebody reconstituting research-grade powder has none of that: the concentration is whatever they made it, the label states a nominal mass that may not be accurate, and nobody looks at the number twice. The Journal has come to think that the useful advice in this area is not exhortation to be careful but the recommendation of structural checks — write the concentration on the vial, recalculate at every new vial, and keep the syringe size constant.
Three reading errors recur. The first is counting marks rather than reading numerals, which fails at the first change of barrel size. The second is reading to the wrong part of the plunger: the measurement is taken at the leading edge of the rubber stopper, not the tip of any conical projection beyond it, and on some designs the difference is a full unit. The third is parallax, which sounds fussy and is not: at small volumes, viewing the barrel from above or below the mark introduces a readable error.
The remedy for all three is the same and takes seconds. Read the numeral, not the count. Hold the barrel at eye level. Identify the leading edge of the stopper before drawing rather than after.
There is a further consideration specific to this market. Syringes sold for general medical use — tuberculin syringes, for instance — are graduated in millilitres and fractions of a millilitre. They are the same size and shape as insulin syringes, and in the same drawer. Using them requires reading a completely different scale, and the failure to notice the substitution is the single commonest route to a tenfold error that we have documented.
Dead space is the volume held in the needle and hub after the plunger has bottomed out. For a fixed-needle insulin syringe it is very small, of the order of two to seven microlitres. For a detachable needle on a conventional luer fitting it is considerably larger, sometimes exceeding fifty microlitres.
Whether that matters is a question of proportion. At an intended volume of two hundred microlitres, a five-microlitre loss is under three per cent and irrelevant. At an intended volume of twenty microlitres — which a concentrated reconstitution produces — the same loss is a quarter of the dose. This is one of the strongest practical arguments against making a vial up to a very high concentration: it pushes the injection volume down into the range where fixed losses dominate.
Air bubbles interact with the same arithmetic. A bubble displaces solution, so a barrel drawn to eight units containing a one-unit bubble delivers seven units of drug. Small bubbles in a subcutaneous injection are not a safety problem in the way they would be intravenously; they are a dosing problem. Expelling them by tapping the barrel upright and pushing the plunger to the mark is a volumetric correction, not a ritual, and it matters most at exactly the small volumes where people are least inclined to bother.
Rotation in this class protects tissue. It is not a dose-control measure, and importing insulin advice wholesale misleads people about that.
On site interchangeabilityThe commonest arithmetic failure in this market is not a miscalculation. It is a correct calculation that has quietly expired. Vials change strength between batches and between suppliers. Diluent volume changes because a different measuring device was used, or because the previous figure was not written down. Neither event produces any visible signal.
Three structural habits prevent it, and exhortations to care do not. Write the concentration and the microgram-per-unit figure on the vial, on tape, at the moment of reconstitution. Recalculate at every new vial from the stated mass and the measured diluent volume, rather than reusing the previous unit count. And do not change syringe barrel size and vial concentration in the same week, because if something then goes wrong there is no way to tell which change caused it.
The Journal notes that this is exactly the class of error a dispensing pharmacist exists to catch, and that in a market where material arrives as unlabelled powder there is no pharmacist. Structural checks are not a counsel of perfection here; they are the only remaining layer.
| Site | Approx. skin thickness | Adequate needle | Risk with 12.7 mm |
|---|---|---|---|
| Abdomen | ≈2.2 mm | 4 mm | Low to moderate |
| Thigh (anterior/lateral) | ≈1.9 mm | 4 mm | Intramuscular in lean limbs |
| Upper arm (posterolateral) | ≈2.2 mm | 4 mm | Intramuscular in lean arms |
| Upper outer buttock | ≈2.4 mm | 4 mm | Low |
| Skin thickness figures are approximate population means from ultrasound studies and vary little with body mass index. Subcutaneous fat thickness varies greatly, which is why the risk column does. | |||
Pen devices require a priming step — commonly a dial to two units and an expulsion until a drop appears at the needle tip — before each injection. It serves two functions: expelling air that has accumulated in the cartridge and needle, and confirming that the device and needle are patent before a dose is dialled.
Skipping it produces an intermittent underdose. Air occupies part of the delivered volume, so some of the dialled dose is gas. Because the loss is variable and invisible, the person experiences an occasional week that felt different rather than a device error, and the habit erodes precisely because the feedback is unreliable.
Two adjacent points belong with it. A pen needle should be attached immediately before use and removed immediately after, because a needle left in place allows solution to leak out and air to be drawn in, which is how cartridges come to contain air in the first place. And the ten-second hold at the end of an injection — plunger fully depressed, needle still in the skin — exists because delivery is not instantaneous at these bore sizes, and withdrawing early leaves part of the dose on the skin. Both are omitted routinely.
Needle points are manufactured sharp, coated and single-use. A single insertion blunts and deforms the tip measurably; electron micrographs of reused needles show visible damage after one use and substantial deformation after several. Reuse is more painful, produces more tissue trauma, and is a documented risk factor for lipohypertrophy.1
It is also extremely common, for reasons that are economic rather than ignorant. Needles cost money, they are sometimes hard to obtain without a prescription, and the harm from reuse is cumulative and invisible rather than immediate. A person reusing a needle is usually making a rational short-term decision with a poorly signposted long-term cost.
Two aggravations are worth stating. A needle left attached to a pen between doses allows leakage out and air in, which is a dosing problem as well as a sterility one. And a needle reused into a vial blunts the stopper, coring rubber fragments into the solution over repeated entries.
The Journal reports the practice without moralising about it, and notes that of all the technique failures in this file, this is the one most responsive to needles simply being cheap and available.2
It arises from the fact that one hundred units and one millilitre are the same volume. A calculated injection volume of 0.1 mL is ten units. A person who reads 0.1 and draws to the mark labelled one has given a tenth of the intended dose; a person who reads ten units and draws to the 1.0 mL mark on a millilitre-graduated barrel has given ten times it.
The vector is almost always a syringe that is not an insulin syringe. Tuberculin syringes and general-purpose 1 mL syringes are the same length, the same colour and often the same price, and they are graduated in hundredths of a millilitre. Nothing about picking up the wrong one feels like an error.
Two structural defences work. Keep one syringe type and one barrel size, and buy them deliberately rather than taking whatever the supplier included. And express the dose in the units of the instrument in use — write "8 units" on the vial tape if you use insulin syringes, and never carry a millilitre figure and a unit figure in the same note where one can be read as the other.
The Journal treats this as the most important paragraph in the file. It is a boring failure with a large magnitude, which is the profile of most real harm in this market.
Technique is the least glamorous subject this publication covers and, measured by the number of things that can go wrong per week, one of the most consequential. A person can read every trial in the class, choose a molecule intelligently, titrate patiently, and then give themselves a tenth of the intended dose because two syringes in a drawer were graduated on different scales. The pharmacology is not what fails in that story.
Selected from correspondence received on this article. Writers are identified by initial, surname and city, verified before printing. Replies are from the desk that filed the piece or from the standards editor. Write to letters@compoundjournal.com.
I gave myself a tenth of my intended dose for five weeks. I had been using insulin syringes, ran out, and used the 1 mL syringes that came with the vials, which are marked in millilitres. I did not notice because the plunger was in roughly the same place. Nobody warned me these were different scales.
— N. Bujanović, Sarajevo
This is the error we rank first for magnitude and we are grateful for the account, because it happened exactly as the mechanism predicts: a substitution that produced no visible signal. The one structural defence is to buy syringes deliberately and keep to a single type rather than using whatever arrives in the parcel.
Nothing in this file addresses what to do when you realise mid-week that you have made an error. I gave double my dose on a Sunday and could find no guidance anywhere about what that meant.
— S. Tovmasyan, Gyumri
A real gap and we will address it properly rather than in a reply. The short version is that it is a pharmacokinetic question — how much excess exposure, over what half-life — and a clinical one about symptom burden, and neither is answerable in the abstract. It also belongs in the titration file, which currently discusses omission and not excess.
You spend a page on the four-line calculation and then publish a reconstitution table anyway. Are you not providing exactly the pre-computed number you warned against?
— H. Okwuosa, Enugu
A fair catch, and the reason the table carries the note it does. It is indexed by both vial mass and diluent volume precisely so that it cannot be read as a single fixed answer, and it is preceded by the derivation. If we thought a reader would take one figure from it and carry that figure across a change of vial, we would remove it.
A needle blunts on first use. Reuse is uncomfortable, and it is a documented contributor to lipohypertrophy.
The evidence base is thin and the document says so, which is to its credit.
A more concentrated reconstitution means smaller injection volumes, which means larger proportional errors from graduation, dead space and technique.
A small number of serious gastrointestinal events occur in people taking these drugs. Distinguishing them from the expected effect profile is the most consequential…
Matching a retention time against a standard is evidence of consistency, not proof of identity. Two different species can elute at the same time on one method.
The same receptor population that produces the therapeutic effect produces the commonest adverse one.